Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page adds footer-level metadata and regulatory context, including FDA-regulated notices, IPD planning, PubMed publications, and related topic links, enhancing access to regulatory information and related resources without altering the study details.
    Difference
    56%
    Check dated 2026-08-17T12:21:01.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.5, indicating a minor update to the study record's metadata.
    Difference
    0.1%
    Check dated 2026-08-10T07:39:04.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4. This appears to be a minor template or platform update with no changes to the study details or user interactions.
    Difference
    0.1%
    Check dated 2026-07-26T19:20:40.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page revision updates to version v3.6.3, signaling a small update to the study record. There are no visible changes to the study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-05T04:34:47.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer published version without describing substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-27T23:26:44.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision shows Revision: v3.6.0. Additionally, the recruitment status was updated to 'No longer looking for participants', signaling that enrollment for this study has closed.
    Difference
    0.4%
    Check dated 2026-06-13T16:25:18.000Z thumbnail image

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.